These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36812119)

  • 1. Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies.
    Fumagalli SE; Padhiar NH; Meyer D; Katneni U; Bar H; DiCuccio M; Komar AA; Kimchi-Sarfaty C
    Virol J; 2023 Feb; 20(1):31. PubMed ID: 36812119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.
    Das JK; Roy S
    Genomics; 2021 Jul; 113(4):2177-2188. PubMed ID: 34019999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the effects of the top 10 synonymous mutations from 26645 SARS-CoV-2 genomes of early pandemic phase.
    Boon WX; Sia BZ; Ng CH
    F1000Res; 2021; 10():1053. PubMed ID: 39268187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2.
    Li G; Zhang L; Xue P
    Infect Genet Evol; 2022 Jan; 97():105175. PubMed ID: 34871776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 continuously optimizes its codon usage to adapt to human lung environment.
    Wang Y; Li Z; Wang X; Jiang W; Jiang W
    J Appl Genet; 2023 Dec; 64(4):831-837. PubMed ID: 37740828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2.
    Huang W; Guo Y; Li N; Feng Y; Xiao L
    Infect Genet Evol; 2021 Apr; 89():104736. PubMed ID: 33516969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV.
    Li G; Zhang L; Du N
    Genes Genomics; 2021 Nov; 43(11):1351-1359. PubMed ID: 34228320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses.
    Saha J; Bhattacharjee S; Pal Sarkar M; Saha BK; Basak HK; Adhikary S; Roy V; Mandal P; Chatterjee A; Pal A
    Gene Rep; 2021 Jun; 23():101055. PubMed ID: 33615042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for Strong Mutation Bias toward, and Selection against, U Content in SARS-CoV-2: Implications for Vaccine Design.
    Rice AM; Castillo Morales A; Ho AT; Mordstein C; Mühlhausen S; Watson S; Cano L; Young B; Kudla G; Hurst LD
    Mol Biol Evol; 2021 Jan; 38(1):67-83. PubMed ID: 32687176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic.
    Mogro EG; Bottero D; Lozano MJ
    Virology; 2022 Mar; 568():56-71. PubMed ID: 35134624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.
    Yuan F; Wang L; Fang Y; Wang L
    Transbound Emerg Dis; 2021 Nov; 68(6):3288-3304. PubMed ID: 33207070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
    Dutta R; Buragohain L; Borah P
    Virus Res; 2020 Oct; 288():198113. PubMed ID: 32771430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and Deoptimization of Codons in SARS-CoV-2 and Related Implications for Vaccine Development.
    Wu X; Shan KJ; Zan F; Tang X; Qian Z; Lu J
    Adv Sci (Weinh); 2023 Aug; 10(23):e2205445. PubMed ID: 37267926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolution of Severe Acute Respiratory Syndrome Coronavirus-2 during Pandemic and Adaptation to the Host.
    Hussain S; Rasool ST; Pottathil S
    J Mol Evol; 2021 Jul; 89(6):341-356. PubMed ID: 33993372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19.
    Khattak S; Rauf MA; Zaman Q; Ali Y; Fatima S; Muhammad P; Li T; Khan HA; Khan AA; Ngowi EE; Wu DD; Ji XY
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in Codon Usage in Coronaviruses Is Mainly Driven by Mutational Bias and Selective Constraints on CpG Dinucleotide.
    Daron J; Bravo IG
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses.
    Tort FL; Castells M; Cristina J
    Virus Res; 2020 Jul; 283():197976. PubMed ID: 32294518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.
    Ghosh N; Saha I; Nandi S; Sharma N
    Methods; 2022 Jul; 203():282-296. PubMed ID: 34547443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biased Mutation and Selection in RNA Viruses.
    Kustin T; Stern A
    Mol Biol Evol; 2021 Jan; 38(2):575-588. PubMed ID: 32986832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mutational Landscape of SARS-CoV-2.
    Saldivar-Espinoza B; Garcia-Segura P; Novau-Ferré N; Macip G; Martínez R; Puigbò P; Cereto-Massagué A; Pujadas G; Garcia-Vallve S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.